Latest news about the Spanish National Cancer Research Centre -

H12O-CNIO Haematological Malignancies Clinical Research Unit

Translational
21.11.2018 Haematologica. A new methodology predicts the risk of relapse in patients with acute myeloid leukemia The acute myeloid leukemia (AML) is the most common haematological cancer in adults. With a 5-year...

21.11.2018 CNIO researchers participate in the 13th Congress of the Spanish Group of Cancer Patients True to its commitment to raise awareness about cancer research, Spanish National Cancer Research...

20.11.2018 Manuel Valiente, selected to become an EMBO Young Investigator The European Molecular Biology Organisation (EMBO) has chosen Manuel Valiente, Head of the Brain...

Events
16.11.2018 Politicians undertake the implementation of urgent measures to protect and promote science in Spain Representatives from member institutions of the Severo Ochoa and María de Maeztu alliance (SOMMa),...

Translational
13.11.2018 European Urology. First blood-based biomarker in response to the treatment of the most aggressive prostate cancer In collaboration with British and Italian researchers

07.11.2018 Scott Lowe, from the Memorial Sloan Kettering, chooses the CNIO for a sabbatical stay in Spain At the 10th edition of the Visiting Researchers Programme run by the Jesús Serra Foundation (from...

Outreach to Society
05.11.2018 CNIO & The City: The history of cancer [Subtitles available in English] Cancer is a disease that has always been present, affecting all...

Translational
05.11.2018 U.S. Department of Defense will finance a new therapeutic approach against the most aggressive type of prostate cancer Coinciding with ‘Movember’, a month that raises awareness of men’s health issues

Basic Research
30.10.2018 Journal of Clinical Investigation. CNIO finds the origin of a type of thrombocytopenia caused by an oncogene The Cell Division and Cancer Group of the Spanish National Cancer Research Centre (CNIO) has...

News